Literature DB >> 20149317

Rheumatoid cachexia and cardiovascular disease.

G S Metsios1, A Stavropoulos-Kalinoglou, V F Panoulas, A Sandoo, T E Toms, A M Nevill, Y Koutedakis, G D Kitas.   

Abstract

OBJECTIVE: It has been frequently stated that rheumatoid cachexia (RC) associates with increased cardiovascular risk; however, no studies to date have investigated this. The aim of this study was to investigate the association of RC with multiple novel and classical cardiovascular disease (CVD) risk factors and the presence of established CVD in rheumatoid arthritis (RA).
METHODS: A total of 34 RA patients with RC (RA+RC) were identified from a database of 400 RA patients using published RC criteria and compared to the remaining patients (RA-RC) who did not fulfil RC criteria. All patients were assessed for fat and fat-free mass, albumin (indicator of catabolism), disease activity/severity, novel and classical risk CVD factors and established CVD.
RESULTS: Fat-free mass (kg) and albumin (g/L) were significantly decreased in RA+RC vs. RA-RC patients: 37.3(33.9-41.6) vs. 45.9(41.2-55.5), p<0.001 and 39.6 + or - 6.7 vs. 42.4 + or - 4.9, p=0.001). Percent body fat was not significantly different. No significant differences were detected in either the classical or novel CVD risk factors, 10-year CVD risk or the prevalence of established CVD.
CONCLUSIONS: RC does not appear to be associated with worse CVD profile in RA patients, but this needs to be confirmed in prospective studies.

Entities:  

Mesh:

Year:  2009        PMID: 20149317

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

Review 1.  Rheumatoid cachexia and cardiovascular disease.

Authors:  Gregory D Summers; Giorgos S Metsios; Antonios Stavropoulos-Kalinoglou; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2010-07-20       Impact factor: 20.543

Review 2.  The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Leena R Baghdadi; Richard J Woodman; E Michael Shanahan; Arduino A Mangoni
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

3.  Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes.

Authors:  M Herly; K Stengaard-Pedersen; K Hørslev-Petersen; M L Hetland; M Østergaard; R Christensen; B B Løgstrup; P Vestergaard; J Pødenphant; P Junker; T Ellingsen
Journal:  BMJ Open       Date:  2017-04-08       Impact factor: 2.692

4.  Prevalence of rheumatoid cachexia in rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Rafaela C E Santo; Kevin Z Fernandes; Priscila S Lora; Lidiane I Filippin; Ricardo M Xavier
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-08-21       Impact factor: 12.910

Review 5.  The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis.

Authors:  Stergios Soulaidopoulos; Elena Nikiphorou; Theodoros Dimitroulas; George D Kitas
Journal:  Front Med (Lausanne)       Date:  2018-02-08

6.  Muscle deterioration due to rheumatoid arthritis: assessment by quantitative MRI and strength testing.

Authors:  Matthew Farrow; John Biglands; Steven Tanner; Elizabeth M A Hensor; Maya H Buch; Paul Emery; Ai Lyn Tan
Journal:  Rheumatology (Oxford)       Date:  2021-03-02       Impact factor: 7.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.